The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Decreased Protection by HDL From Poorly Controlled Type 2 Diabetic Subjects Against LDL Oxidation May Be Due to the Abnormal Composition of HDL
Open accessAbstract
Abstract—High plasma triglyceride concentrations in diabetic subjects increase their risk for developing coronary heart disease. Numerous studies have shown that the high density lipoprotein (HDL) composition is abnormal in type 2 diabetic subjects. One study has shown that HDL (lipoprotein A-I) isolated from subjects with non–insulin-dependent diabetes mellitus exhibits a decreased capacity to induce cholesterol efflux. The current study examined the effect of HDL 2 and HDL 3 subfractions from poorly controlled type 2 diabetic and control subjects on THP-1 macrophage–mediated low density lipoprotein (LDL) oxidation. The composition and protective effects of HDL 2, but not of HDL 3, differed significantly between control and diabetic subjects. HDL 2 from diabetics were triglyceride enriched and cholesterol depleted compared with those from controls. Control HDL 2 inhibited LDL oxidation, as assessed by lipid peroxides and electrophoretic mobility, significantly (P<0.05) more than did diabetic HDL 2 in both the fasting and postprandial state. In addition, HDL 2 from diabetics did not protect against apolipoprotein B-100 fragmentation in LDL. Cross-linking in apolipoprotein A-I, oxidized in the presence of LDL, was extensive in HDL 2 from diabetics compared with that from controls. Serum triglyceride concentrations were negatively correlated with protection by HDL 2(r=−0.673,P<0.05) in diabetic but not in control subjects. HDL 2-associated platelet-activating factor acetylhydrolase activity was positively correlated with protection by HDL 2 in control (r=0.872,P<0.002) but not in diabetic subjects. In conclusion, compositional alterations in HDL 2 from poorly controlled type 2 diabetic subjects may reduce its antiatherogenic properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patsch, J. R., Karlin, J. B., Scott, L. W., Smith, L. C., & Gotto, A. M. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.5.1449 · Cited by 386
Cited by
Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management
Beckman, J. A., Creager, M. A., & Libby, P. (2002) · JAMA · doi:10.1001/jama.287.19.2570 · Cited by 2,724
Authors/Task Force Members, Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,647
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394
Kontush, A., & Chapman, M. J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.1 · Cited by 647
HDL and arteriosclerosis: beyond reverse cholesterol transport
Nofer, J.-R., Kehrel, B., Fobker, M., Levkau, B., Assmann, G., & Eckardstein, A. V. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00651-7 · Cited by 595
Metadata
- Authors
- Gowri, M. S., Van der Westhuyzen, D. R., Bridges, S. R., & Anderson, J. W.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1999-09
- Volume
- 19
- Issue
- 9
- Pages
- 2226-2233
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2143047624
- Cited by
- 164
- References
- 1
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Decreased Protection by HDL From Poorly Controlled Type 2 Diabetic Subjects Against LDL Oxidation May Be Due to the Abnormal Composition of HDL. https://app.cochat.ai/papers/10.1161/01.atv.19.9.2226
- The paper
- Gowri, M. S., Van der Westhuyzen, D. R., Bridges, S. R., & Anderson, J. W. (1999). Decreased Protection by HDL From Poorly Controlled Type 2 Diabetic Subjects Against LDL Oxidation May Be Due to the Abnormal Composition of HDL. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/01.atv.19.9.2226
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.